Ignite Creation Date:
2025-12-24 @ 11:28 PM
Ignite Modification Date:
2026-01-05 @ 6:37 PM
Study NCT ID:
NCT04972656
Status:
RECRUITING
Last Update Posted:
2022-09-28
First Post:
2021-07-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment With Ambrisentan in Patients With Borderline Pulmonary Arterial Hypertension
Sponsor:
Nanjing First Hospital, Nanjing Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CSC20210527
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |